A new carbapenem agent for the control of severe infection caused by the most agressive nosocomial strains in critically ill patients (2016)
- Authors:
- USP affiliated authors: SILVA JUNIOR, CARLINDO VIEIRA DA - FCF ; SANTOS, SILVIA REGINA CAVANI JORGE - FCF
- Unidade: FCF
- Assunto: CONTROLE DE INFECÇÕES
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Brazilian Journal of Pharmaceutical Sciences
- ISSN: 1984-8250
- Volume/Número/Paginação/Ano: v. 52, suppl. 1, p. 10 res. FCF015, 2016
- Conference titles: Pharmaceutical Sciences and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo
-
ABNT
SOUSA, Ednalva Maria de et al. A new carbapenem agent for the control of severe infection caused by the most agressive nosocomial strains in critically ill patients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 24 abr. 2024. , 2016 -
APA
Sousa, E. M. de, Silva Junior, C. V., Gomez, D. de S., & Santos, S. R. C. J. (2016). A new carbapenem agent for the control of severe infection caused by the most agressive nosocomial strains in critically ill patients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Sousa EM de, Silva Junior CV, Gomez D de S, Santos SRCJ. A new carbapenem agent for the control of severe infection caused by the most agressive nosocomial strains in critically ill patients. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 10 res. FCF015.[citado 2024 abr. 24 ] -
Vancouver
Sousa EM de, Silva Junior CV, Gomez D de S, Santos SRCJ. A new carbapenem agent for the control of severe infection caused by the most agressive nosocomial strains in critically ill patients. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 10 res. FCF015.[citado 2024 abr. 24 ] - Does the amikacin effectiveness is reached in septic critically ill patient after the empirical daily dose against gram-negative mic 32mg/l strains?
- PK/PD correlation of vancomycin for dose adjustment for the control of infections in pediatric critical burn patients
- Correlação PK/PD de carbapenêmicos em pacientes críticos pediátricos grandes queimados para o controle da sepse
- Vancomycin daily dose recommended to pediatric septic burn patients against staphylococcus spp. and effectiveness based on ratio area under the curve and mic
- Triazoles or echinocandins antifungal therapy against candida glabrata in sepsis?
- PK modeling of vancomycin-piperacillin for the control of severe infections in critical burn patients for dose adjustment purpose
- Is vancomycin therapeutic target against Staphylococcus SPP MIC1mg/L achieved after the empirical dose regimen recommended to critically septic pediatrics?
- Vancomycin pk/pd correlation for the control of infection in critical burn patients with sepsis
- Vancomycin effectiveness by PK/PD correlation in burn patients
- PK/PD correlation for imipenem effectiveness in burn patients
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
